Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin

Drug Development and Industrial Pharmacy

Volumn 39, Issue 7, 2013, Pages 970-977

  Mummidi, Varalakshmi ^a   Jayanthi, Vijayaratna ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Complexation; Dissolution rate; Hydrophilic polymers; Hydroxypropyl cyclodextrin; Isradipine

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ISRADIPINE; POLYMER;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

BETA-CYCLODEXTRINS; CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; ISRADIPINE; METHYLCELLULOSE; POLYETHYLENE GLYCOLS; POLYMERS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84878822324     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.686508     Document Type: Article

References (22)

1. Fromming KH, Szejtli J. CDs in Pharmacy. Dordrecht, The Netherlands: Kluwer Academic Publishers. 1994:1-81.
2. Duchene D, Wouessidjewe D. Pharmaceutical and medicinal applications of cyclodextrins. In: Dumitriu S, editors. Polysaccharides in Medical Applications. New York: Marcel Dekker, 1996:575-602.
3. Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin Drug Carrier Systems. Chem Rev, 98:2045-2076.
4. Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci, 85:1017-1025.
5. Rajewski RA, Stella VJ. (1996). Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci, 85:1142-1169.
6. Reddy MN, Rehana T, Ramakrishna S, Chowdhary KP, Diwan PV. (2004). Beta-cyclodextrin complexes of celecoxib: molecularmodeling, characterization, and dissolution studies. AAPS PharmSci, 6:E7.
7. Ozdemir N, Erkin J. (2012). Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with ß-cyclodextrin. Drug Dev Ind Pharm, 38:331-340.
8. Lu Y, Zhang T, Tao J, Ji G, Wang S. (2009). Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin. Drug Dev Ind Pharm, 35:1452-1459.
9. Szejtli J. (1994). Medicinal applications of cyclodextrins. Med Res Rev, 14:353-386.
10. Pitha J. Cyclodextrin derivatives with enhanced solubility power and lower toxicity. Proc. of 9th Int. Symposium on Cyclodextrins, Santiago de Compostela. 1998:210-215.
11. Yan Z, Xu W, Sun J, Liu X, Zhao Y, Sun Y et al. (2008). Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin. Drug Dev Ind Pharm, 34:632-641.
12. Wang S, Ding Y, Yao Y. (2009). Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-betacyclodextrin. Drug Dev Ind Pharm, 35:808-813.
13. Borghetti GS, Pinto AP, Lula IS, Sinisterra RD, Teixeira HF, Bassani VL. (2011). Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev Ind Pharm, 37:886-893.
14. Cirri M, Righi MF, Maestrelli F, Mura P, Valleri M. (2009). Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers. Drug Dev Ind Pharm, 35:73-82.
15. Isradipine capsules, United state pharmacopeia 29-NF 24, 1209.
16. Horst FS, James MJ, Leonard MG. Clinical Pharmacokinetics of Isradipine. American Journal of Medicine 1988;81(3B):80-89.
17. Sustained release delivery of isradipine, USPTO patent application 20060210623.
18. Higuchi T, Connors KA. Phase-solubility techniques. In: Reilly CN, ed. Advances in Analytical Chemistry and Instrumentation. New York, NY: Wiley-Interscience 1965:117-212.
19. Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol, 27:48-49.
20. Douglas AS, James HF, Stanley RC. Principles of Instrumental analysis. Australia: Thomson Brooks/Cole Publisher, 2007:894-906.
21. Ryan JA. (1986). Compressed pellet X-ray diffraction monitoring for optimization of crystallinity in lyophilized solids: imipenem: cilastatin sodium case. J Pharm Sci, 75:805-807.
22. Calabrò ML, Tommasini S, Donato P, Raneri D, Stancanelli R, Ficarra P et al. (2004). Effects of alpha- and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones. J Pharm Biomed Anal, 35:365-377.